Clinical feasibility of chairside methylene blue-mediated photodynamic therapy for oral candidiasis
Peiru Zhou, Furong Yang, Jiakun Fang, Jiangli Zheng, Yanhong Meng, Xu Zhang, Hong Hua · 2026
Read Clinical feasibility of chairside methylene blue-mediated photodynamic therapy for oral candidiasis by Peiru Zhou, Furong Yang, Jiakun Fang, Jiangli Zheng, Yanhong Meng, Xu Zhang, Hong Hua (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13474966.txt.
Description
Peiru Zhou and six colleagues tested in 2026 a chairside light-activated treatment for oral thrush, comparing it with standard nystatin lozenges. Eighteen patients were randomised to methylene blue photodynamic therapy three times weekly or nystatin three times daily, both for two weeks.
Both groups improved markedly, with clinical response at 66.7 percent for light therapy and 88.9 percent for nystatin, and no serious side effects. Fungal clearance and overall response also favoured nystatin, but none of the gaps reached statistical significance in this small pilot. Two patients dropped out. Light therapy proved feasible and tolerable, while its antifungal power needs larger trials.
Catalog record
| CREATOR | Peiru Zhou, Furong Yang, Jiakun Fang, Jiangli Zheng, Yanhong Meng, Xu Zhang, Hong Hua |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |